Hermed Capital Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 6

Professionals

  • Investments
  • 16

  • Portfolio
  • 11

  • Exits
  • 4

Exits

Hermed Capital General Information

Company Description

Hermed Capital is a private equity and venture capital firm that invests in the healthcare industry. The firm prefers to invest in companies within the pharmaceuticals, medical device and diagnostic and medical services sectors. Hermed Capital is based in Shanghai, China.

Business Details

Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Other Investor Types
Growth/Expansion
Corporate Office
  • Room.308, Building A
  • Number 1289, Yishan Road
  • Shanghai
  • China
+86 00000000000

Hermed Capital Investments (16)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
BD Gene Therapeutics 26-Jun-2023 Early Stage VC 0000 Drug Discovery Clinical Trials - General
Enzymetree 02-Jun-2023 00000 00000 000.00 Multi-line Chemicals Generating Revenue 0000 000000 00.0
Lukin Medical 16-May-2023 00000 00000 00.000 Surgical Devices Generating Revenue 0000 000000 00.0
Aubrak Therapeutics 25-Mar-2022 00000 00000 000.00 Drug Discovery Clinical Trials - General
Abmtx 04-Jan-2022 00000 00000 0000 Drug Discovery Generating Revenue
MitrAssist 02-Dec-2020 00 000000000 0000 Therapeutic Devices Generating Revenue
Hinova Pharmaceuticals 24-Aug-2020 00000 00000 0000 Drug Discovery Generating Revenue/Not Profitable
Spineology 02-Oct-2019 00 000000000 000.00 Surgical Devices Generating Revenue 0000 000000 00.0
Hinova Pharmaceuticals 26-Jul-2019 Later Stage VC 0000 Drug Discovery Generating Revenue/Not Profitable
Prognos Health 03-Nov-2017 Later Stage VC 000.00 Enterprise Systems (Healthcare) Generating Revenue
You’re viewing 10 of 16 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Hermed Capital Exits (4)

Company Name Exit Date Exit Type Exit Size
Applied StemCell 09-Oct-2023 Buyout/LBO
Hinova Pharmaceuticals 12-Apr-2022 000 00000
Aadi Bioscience 27-Aug-2021 Reverse Merger
DiaMedica Therapeutics Secondary Transaction - Open Market
To view Hermed Capital’s complete exits history, request access »

Hermed Capital Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Hermed Capital Management, Team & Partners (9)

Name Title Deals Funds Boards Office
Xiao Zhenyu Ph.D Managing Director 0 0 0 Shanghai, China
Garry Gong Investment Director Shanghai, China
Fang Yao Investment Committee Member 0 Shanghai, China
Hanson Wu Executive Director Shanghai, China
Qiang Zhao Executive Director Shanghai, China
You’re viewing 5 of 9 team members. Get the full list »

Hermed Capital Co-Investors (23)

Name With Exits Lead Partner Series Industry
Delta Capital 1 Series chart Industry bar
Fosun Pharma 0 0 Series chart Industry bar
Highlight Capital 0 Series chart Industry bar
Power Capital 0 0 Series chart Industry bar
Suzhou Guofa Venture Capital 0 0 Series chart Industry bar
You’re viewing 5 of 23 co-investors. Get the full list »

Hermed Capital FAQs

  • What is Hermed Capital?

    Hermed Capital is a private equity and venture capital firm that invests in the healthcare industry.

  • Where is Hermed Capital headquartered?

    Hermed Capital is headquartered in Shanghai, China.

  • What is Hermed Capital's total asset value?

    Hermed Capital has around 00000 in total assets under management.

  • How many investments has Hermed Capital made?

    Hermed Capital has made 16 investments.

  • What has Hermed Capital invested in?

    Hermed Capital has made numerous investments in companies like BD Gene Therapeutics, Enzymetree, and Lukin Medical within the Drug Discovery, Multi-line Chemicals, and Surgical Devices industries.

  • What has Hermed Capital invested in recently?

    Hermed Capital's latest investment was on 26-Jun-2023 in BD Gene Therapeutics, a company within the Drug Discovery industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »